Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Green, innovative oral capsules of three anti-Parkinson's drugs: formulation, in vitro evaluation, and robust RP-HPLC validation
Samar M.
Mahgoub
a,
Abdullah S.
Alawam
b,
Hassan A.
Rudayni
b,
Ahmed A.
Allam
b,
Khaled Hesham
Ezzat
c,
Saber A. A.
Elsuccary
d,
Abdelatty M.
Radalla
e and
Rehab
Mahmoud
*e
aMaterials Science and Nanotechnology Department, Faculty of Postgraduate Studies for Advanced Sciences, Beni-Suef University, Egypt. E-mail: miramar15@yahoo.com
bDepartment of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia. E-mail: asalawam@imamu.edu.sa; harudayni@imamu.edu.sa; aallam@imamu.edu.sa
cFormulation and Development Department, Faculty of Pharmacy, 6th of October University, Egypt. E-mail: Khaled.hesham.ezzat@gmail.com
dDepartment of Chemistry, College of Science, United Arab Emirates University, United Arab Emirates. E-mail: s.abdulhamid@uaeu.ac.ae
eDepartment of Chemistry, Faculty of Science, Beni-Suef University, Beni-Suef 62528, Egypt. E-mail: abdelaty.mohamed@science.bsu.edu.eg; rehabkhaled@science.bsu.edu.eg
First published on 28th August 2025
Abstract
Correction for ‘Green, innovative oral capsules of three anti-Parkinson's drugs: formulation, in vitro evaluation, and robust RP-HPLC validation’ by Samar M. Mahgoub et al., Anal. Methods, 2025, 17, 6215–6230, https://doi.org/10.1039/D5AY00698H.
The authors sincerely apologise for providing an incorrect grant number in their Acknowledgements. The correct attribution of their funding is as follows:
This work was supported and funded by the Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU) (grant number IMSIU-DDRSP2501).
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2025 |